C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 58/100How is this calculated?

TLRY Earnings Test: EBITDA Growth Must Become Cash

Tilray’s fiscal 2027 outlook raises the key global cannabis-equity question: can adjusted EBITDA growth convert into free cash flow without further dilution?

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.